Diltiazem Hydrochloride
NDC 70436-193, Diltiazem Hydrochloride, capsule, extended release, from Slate Run Pharmaceuticals, LLC.
- Product NDC
- 70436-193
- Status
- Listed
- Labeler
- Slate Run Pharmaceuticals, LLC
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA216304
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70436-193 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DILTIAZEM HYDROCHLORIDE240 mg/1
Pharmacologic classes
Calcium Channel Antagonists [MoA]; Calcium Channel Blocker [EPC]; Cytochrome P450 3A4 Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70436-193-01 | 70436019301 | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70436-193-01) |
| 70436-193-02 | 70436019302 | 500 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (70436-193-02) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/e66665e8-22eb-f5cd-e053-2a95a90a72e4NADAC price for package 70436019301
GET /v1/drugs/nadac/70436019301
Use it
Look up 70436-193 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70436-193 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70436-193. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.